C. albicans appendicitis in a neutropenic patient after induction chemotherapy
R. Mehta, D. Cohen
{"title":"C. albicans appendicitis in a neutropenic patient after induction chemotherapy","authors":"R. Mehta, D. Cohen","doi":"10.12788/J.CMONC.0032","DOIUrl":null,"url":null,"abstract":"A 62-year-old white man with a past medical history of hypertension and essential thrombocytosis diagnosed 17 years ago presented at our institution. He was being treated with hydroxyurea, with which he required occasional blood transfusions and platelets were controlled around 400 10/L range. Over a 2-month period, he developed gradually worsening exertional dyspnea, fatigue, decreased appetite, lost about 8 lb in weight. He was found to be pancytopenic, with a total white cell count of 3.26 10/L (normal, 3.8-10.6 10/L), his hemoglobin level was 7.9 gm/dL (normal, 12.9-16.9 gm/ dL), and his platelet count, 46 10/L. A bone marrow aspirate and biopsy revealed 100% cellularity, approximately 8%-10% CD34 positive blasts, and numerous atypical and hypolobated dysplastic megakaryocytes with increased reticulin fibrosis. He was diagnosed with myelofibrosis with underlying myeloproliferative disorder, which seemed to be progressing into a more accelerated phase. He was admitted for induction chemotherapy with cytarabine and idarubicin as a bridge to a matched allogeneic stem cell transplant. He completed 3 days of cytarabine 100 mg/m and 7 days of idarubicin 12 mg/m via a Hickman central venous indwelling catheter. On day 7 of the treatment, as his absolute neutrophil count dropped to 0.9 10/L, he was started on prophylactic ciprofloxacin 500 mg p.o. BID, and acyclovir 400 mg p.o. TID. Fluconazole was held due to mild hyperbilirubinemia (total bilirubin, 2.2 mg/dL [normal, 0.3-1.5 mg/dL]). On day 11, he spiked a fever of 100.5°F when his absolute neutrophil count was 0.4 10/L (normal, 0.8-3.6 10/L). He was started on cefepime; 2 days later, intravenous vancomycin was added as he continued to have intermittent fevers. He was asymptomatic and had no obvious source of infection. His intravenous catheter site appeared clean and nontender, and his blood and urine cultures were negative as was his chest X-ray. However, as he continued to have intermittent high-grade fevers up to 102.5°F, despite broad spectrum antimicrobials, consultation was sought from the infectious disease physician. On day 15, he was started on voriconazole 400 mg BID. The results of an Aspergillus galactomannan antigen test was negative (0.1; reference range, 0.5). On day 18, the patient developed mild right lower quadrant abdominal pain associated with mild dyspnea at rest. On examination, he was in mild distress due to pain. His blood pressure was 114 /80 mmHg; heart rate, 80 beats/min; respiratory rate, 28 breaths/min; pulse oximetry, 94% on 2-liter nasal cannula oxygen. His lungs were clear to auscultation. The patient was mildly tender in right lower quadrant with mild guarding but no rebound tenderness. Bowel sounds were present. A computed tomography (CT) scan of abdomen and pelvis with contrast showed a dilated appendix up to 1.3 cm in diameter with surrounding fat stranding suggestive of acute appendicitis. No fluid collection or dilated bowel loops were noted (Figure 1). A CT scan of the chest with contrast showed multiple bilateral lung nodular opacities; the largest one in the right middle lobe, was 3 cm in size. The patient underwent emergency laparotomy and appendectomy, which revealed the presence of an inflamed appendix adherent to the right pelvis side wall, with no gross evidence of tumor. On gross pathological examination, the vermiform appendix showed roughened serosal surface with fibrous adhesions. The appendiceal wall was thickened and focally hemorrhagic. Grey-tan exudate was noted within the lumen. No gross perforation was identified. Histological sections showed an Manuscript received April 22, 2013; accepted May 6, 2013. Correspondence Rohtesh S. Mehta, MD, MPH, MS, Division of Hematology/Oncology, UPMC Cancer Pavilion, Room 463, 5150 Centre Avenue Pittsburgh, PA 15232 (mehtars@upmc.edu). Disclosure The authors have no disclosures. Commun Oncol 2013;10:244-246 © 2013 Frontline Medical Communications DOI: 10.12788/j.cmonc.0032 Letters Case Letter","PeriodicalId":72649,"journal":{"name":"Community oncology","volume":"10 1","pages":"244-246"},"PeriodicalIF":0.0000,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/J.CMONC.0032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
A 62-year-old white man with a past medical history of hypertension and essential thrombocytosis diagnosed 17 years ago presented at our institution. He was being treated with hydroxyurea, with which he required occasional blood transfusions and platelets were controlled around 400 10/L range. Over a 2-month period, he developed gradually worsening exertional dyspnea, fatigue, decreased appetite, lost about 8 lb in weight. He was found to be pancytopenic, with a total white cell count of 3.26 10/L (normal, 3.8-10.6 10/L), his hemoglobin level was 7.9 gm/dL (normal, 12.9-16.9 gm/ dL), and his platelet count, 46 10/L. A bone marrow aspirate and biopsy revealed 100% cellularity, approximately 8%-10% CD34 positive blasts, and numerous atypical and hypolobated dysplastic megakaryocytes with increased reticulin fibrosis. He was diagnosed with myelofibrosis with underlying myeloproliferative disorder, which seemed to be progressing into a more accelerated phase. He was admitted for induction chemotherapy with cytarabine and idarubicin as a bridge to a matched allogeneic stem cell transplant. He completed 3 days of cytarabine 100 mg/m and 7 days of idarubicin 12 mg/m via a Hickman central venous indwelling catheter. On day 7 of the treatment, as his absolute neutrophil count dropped to 0.9 10/L, he was started on prophylactic ciprofloxacin 500 mg p.o. BID, and acyclovir 400 mg p.o. TID. Fluconazole was held due to mild hyperbilirubinemia (total bilirubin, 2.2 mg/dL [normal, 0.3-1.5 mg/dL]). On day 11, he spiked a fever of 100.5°F when his absolute neutrophil count was 0.4 10/L (normal, 0.8-3.6 10/L). He was started on cefepime; 2 days later, intravenous vancomycin was added as he continued to have intermittent fevers. He was asymptomatic and had no obvious source of infection. His intravenous catheter site appeared clean and nontender, and his blood and urine cultures were negative as was his chest X-ray. However, as he continued to have intermittent high-grade fevers up to 102.5°F, despite broad spectrum antimicrobials, consultation was sought from the infectious disease physician. On day 15, he was started on voriconazole 400 mg BID. The results of an Aspergillus galactomannan antigen test was negative (0.1; reference range, 0.5). On day 18, the patient developed mild right lower quadrant abdominal pain associated with mild dyspnea at rest. On examination, he was in mild distress due to pain. His blood pressure was 114 /80 mmHg; heart rate, 80 beats/min; respiratory rate, 28 breaths/min; pulse oximetry, 94% on 2-liter nasal cannula oxygen. His lungs were clear to auscultation. The patient was mildly tender in right lower quadrant with mild guarding but no rebound tenderness. Bowel sounds were present. A computed tomography (CT) scan of abdomen and pelvis with contrast showed a dilated appendix up to 1.3 cm in diameter with surrounding fat stranding suggestive of acute appendicitis. No fluid collection or dilated bowel loops were noted (Figure 1). A CT scan of the chest with contrast showed multiple bilateral lung nodular opacities; the largest one in the right middle lobe, was 3 cm in size. The patient underwent emergency laparotomy and appendectomy, which revealed the presence of an inflamed appendix adherent to the right pelvis side wall, with no gross evidence of tumor. On gross pathological examination, the vermiform appendix showed roughened serosal surface with fibrous adhesions. The appendiceal wall was thickened and focally hemorrhagic. Grey-tan exudate was noted within the lumen. No gross perforation was identified. Histological sections showed an Manuscript received April 22, 2013; accepted May 6, 2013. Correspondence Rohtesh S. Mehta, MD, MPH, MS, Division of Hematology/Oncology, UPMC Cancer Pavilion, Room 463, 5150 Centre Avenue Pittsburgh, PA 15232 (mehtars@upmc.edu). Disclosure The authors have no disclosures. Commun Oncol 2013;10:244-246 © 2013 Frontline Medical Communications DOI: 10.12788/j.cmonc.0032 Letters Case Letter
诱导化疗后中性粒细胞减少患者的白色念珠菌阑尾炎
一位62岁的白人男性,既往有高血压病史,17年前诊断为原发性血小板增多症。他正在接受羟脲治疗,他需要偶尔输血,血小板控制在40010 /L左右。在2个月的时间里,他出现逐渐加重的用力性呼吸困难,疲劳,食欲下降,体重减轻约8磅。发现全细胞减少,白细胞总数3.26 10/L(正常,3.8-10.6 10/L),血红蛋白水平7.9 gm/dL(正常,12.9-16.9 gm/dL),血小板计数46 10/L。骨髓抽吸和活检显示100%的细胞,约8%-10%的CD34阳性母细胞,大量非典型和低分化的发育不良巨核细胞伴网状蛋白纤维化增加。他被诊断为骨髓纤维化和潜在的骨髓增生性疾病,似乎正在进入一个更加速的阶段。他入院接受阿糖胞苷和伊达柔比星的诱导化疗,作为匹配的异体干细胞移植的桥梁。患者通过Hickman中心静脉留置导管给予阿糖胞苷100 mg/m 3天,伊达柔比星12 mg/m 7天。治疗第7天,中性粒细胞绝对计数下降到0.9 10/L,开始预防性使用环丙沙星500mg p.o. BID,阿昔洛韦400mg p.o. TID。氟康唑因轻度高胆红素血症(总胆红素,2.2 mg/dL[正常,0.3-1.5 mg/dL])而停药。第11天,患者发热100.5°F,绝对中性粒细胞计数0.4 10/L(正常,0.8-3.6 10/L)。他开始服用头孢吡肟;2天后,患者继续出现间歇性发热,给予静脉注射万古霉素。患者无症状,无明显传染源。他的静脉导管部位干净无触痛,他的血和尿培养呈阴性,胸部x光片也是如此。然而,尽管使用了广谱抗菌素,但由于患者持续出现高达102.5华氏度的间歇性高热,因此向传染病医生求诊。第15天开始使用伏立康唑400mg BID。半乳甘露聚糖曲霉抗原检测结果为阴性(0.1;参考范围,0.5)。第18天,患者休息时出现轻度右下腹腹痛并伴有轻度呼吸困难。经检查,他因疼痛而有轻微的痛苦。血压为114 /80 mmHg;心率:80次/分;呼吸频率:28次/分;脉搏血氧测量,2升鼻插管94%。他的肺部听诊正常。患者右下腹轻度压痛,伴轻度守卫,无反跳压痛。有肠音。腹部和骨盆CT造影剂显示阑尾扩张,直径达1.3 cm,周围有脂肪堆积,提示急性阑尾炎。未见积液或肠袢扩张(图1)。胸部CT扫描显示双侧肺多发结节性混浊;最大的位于右中叶,大小为3cm。患者接受了紧急剖腹手术和阑尾切除术,结果显示阑尾炎性附着于右侧骨盆侧壁,未见明显肿瘤迹象。大体病理检查,蚓状阑尾浆膜表面粗糙,纤维粘连。阑尾壁增厚,局部出血。管腔内可见灰褐色渗出物。未发现明显穿孔。组织学切片显示一篇收到于2013年4月22日的稿件;2013年5月6日录用。Rohtesh S. Mehta,医学博士,公共卫生硕士,硕士,血液学/肿瘤学部门,UPMC癌症馆,463室,5150中心大道匹兹堡,PA 15232 (mehtars@upmc.edu)。作者没有任何披露。common Oncol 2013;10:24 -246©2013 Frontline Medical Communications DOI: 10.12788/j.cmonc.0032案例信函
本文章由计算机程序翻译,如有差异,请以英文原文为准。